Non-hormonal steroid modulators of NF-kB for treatment of disease
AssigneeReveraGen BioPharma, Inc.
InventorsJohn M. McCall, Eric Hoffman, Kanneboyina Nagaraju
Life of this patent
Estimating the term…
Abstract
Provided herein is a pharmaceutical composition comprising a compound having the structural formula wherein the compound is present in an amount effective to treat or reduce the symptoms of muscular dystrophy. The therapeutically effective amount may be between 10 mg to 200 mg, or may be between 0.01 mg/kg to 10.0 mg/kg. Also provided are methods of treating or reducing the symptoms of muscular dystrophy, comprising the administration, to a patient in need thereof, of a therapeutically effective of the above compound.
Claims21
An oral pharmaceutical composition comprising a compound having the structural formula
- comprising a therapeutically effective amount of the compound in a suspension.
A method of treating or reducing the symptoms of muscular dystrophy, comprising the administration, to a patient in need thereof, of a therapeutically effective amount of a compound having the structural formula
- wherein the therapeutically effective amount is between 10 mg to 200 mg.
A method of treating or reducing the symptoms of muscular dystrophy, comprising the administration, to a patient in need thereof, of a therapeutically effective amount of a compound having the structural formula
- wherein the therapeutically effective amount is between 0.01 mg/kg to 10.0 mg/kg.
Dependencies are inferred from the claim text.